Figure 1).

Comparison of weight loss during hepatitis C virus (HCV) treatment between those eventually initiating oral cannabinoid-containing medication use (solid line) and nonrecipients (dashed line). This analysis excluded patients who began oral cannabinoid-containing medication use in the initial four weeks of HCV therapy